AgBio

A broadly based, multidisciplinary business sector which is subject to regulation in certain technical areas on a jurisdictional basis, and is impacted by a variety of factors at every level.   

An overriding fundamental issue for the sector is how global food production can be intensified to feed a projected nine billion people by 2050, whilst dealing with impacts of climate change.   

Improvements in efficiency and sustainability in agriculture continue to drive ingenious solutions that harness various cutting-edge technologies, such as genomics and CRISPR gene editing, big data, algorithms and AI.  As such, inventions in this sector increasingly involve crossover technologies, requiring the pooling of expertise and effort amongst HGF’s life scientists, chemists and electronics and software attorneys. 

Regulatory aspects govern many plant protection product inventions, and additional levels of IP protection can be available via Supplementary Protection Certificates (SPCs).  There are also potential Convention on Biological Diversity and Nagoya Protocol constraints which can present particular R & D hurdles, and IP issues for inventions which use certain biological materials and their derivatives.  

HGF has the corresponding necessarily specialised and multidisciplinary team of attorneys and lawyers for dealing with IP in this sector. The AgBio and Agritech team is comprised of technically and commercially experienced attorneys, including senior ex-Global 500 company attorneys who provide additional levels of commercial experience and acumen.  Where IP issues are more legal rather than technical, our team adjusts to include or be led by solicitors who are highly experienced in contract negotiation, litigation or management level briefings on IP issues developing technology areas.    

HGF’s attorneys deal with inventions in accelerated plant breeding procedures, genetically engineered or modified crops, actives and formulations for plant protection products, diagnostics, precision and digital agriculture, genetically engineered or modified animals, improved husbandry methods and carbon neutral systems.

Latest updates

Event - 20th September 2021

German Biotechnology days 2021

HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …

Event details

IAM Patent 1000 2021

The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

Searching for the distinctive

How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our agbio specialists.